An observational study in Endometriosis, sponsored by IVI Vigo. Status unknown. Open to female participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2017-11-24.
Sponsored by IVI Vigo · Observational
The purpose of this study is to evaluate if there are differences in oocyte quality depending on whether these oocytes come from an ovary in contact with an endometrioma.
There is no consensus for whether an endometrioma influences oocyte quality, as well as the possible mechanisms that induce them.
In this study, the oocyte maturation will proof oocyte quality: This mean, the percentage of oocytes in metaphase II obtained after stimulation, as well as the rate of oocytes fertilized in direct contact with an endometrioma.
921 studies on the registry are indexed under Endometriosis; 267 are open to participants now.
This study's enrollment of 80 is below the median of 135 across 349 observational studies indexed under Endometriosis.
Browse Endometriosis studies →IVI Vigo is the lead sponsor of 9 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients \<40 years, BMI \<30kg / m2,
Exclusion Criteria:
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
No drugs are administered. It is an observational study. Collect retrospectively data
Other: Collect retrospectively data
No drugs are administered. It is an observational study. Collect retrospectively data
Other: Collect retrospectively data
Collect retrospectively data
Percentage of mature oocytes
Number of MII oocytes from the total of cumulus granulosa cell-oocyte complex by 100
Time frame: Up to 36 months
Fertilization rate
Number of oocytes with pronuclear activation after ICSI procedure from the total oocytes microinjected by 100
Time frame: Up to 36 months
No study locations are listed for this record.
Plan to share: No
The record gives a start of Jan 2017, a primary completion of Nov 2017 and a completion of Jan 2018. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IVI Vigo